Hsbc Holdings PLC Global Blood Therapeutics, Inc. Transaction History

Hsbc Holdings PLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $6.15 Million - $12.9 Million	189,723 New	189,723 $12.9 Million
Q2 2022 Aug 11, 2022	SELL	$22.3 - $37.39 $790,111 - $1.32 Million	-35,431 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$25.68 - $35.59 $1.84 Million - $2.55 Million	-71,635 Reduced 66.91%	35,431 $1.23 Million
Q4 2021 Feb 11, 2022	BUY	$24.9 - $40.26 $139,265 - $225,174	5,593 Added 5.51%	107,066 $3.13 Million
Q3 2021 Nov 12, 2021	BUY	$25.48 - $37.34 $876,766 - $1.28 Million	34,410 Added 51.31%	101,473 $2.61 Million
Q2 2021 Aug 13, 2021	BUY	$32.46 - $43.42 $861,585 - $1.15 Million	26,543 Added 65.51%	67,063 $2.35 Million
Q1 2021 May 14, 2021	SELL	$38.94 - $50.85 $232,900 - $304,133	-5,981 Reduced 12.86%	40,520 $1.65 Million
Q4 2020 Feb 25, 2021	SELL	$37.65 - $63.77 $288,587 - $488,797	-7,665 Reduced 14.15%	46,501 $2.01 Million
Q4 2020 Feb 12, 2021	BUY	$37.65 - $63.77 $1.61 Million - $2.72 Million	42,710 Added 372.82%	54,166 $2.35 Million
Q3 2020 Nov 12, 2020	BUY	$52.76 - $74.49 $233,304 - $329,394	4,422 Added 62.87%	11,456 $632,000
Q2 2020 Aug 14, 2020	SELL	$48.73 - $81.82 $2.57 Million - $4.32 Million	-52,789 Reduced 88.24%	7,034 $444,000
Q1 2020 May 15, 2020	BUY	$41.72 - $87.2 $2.25 Million - $4.7 Million	53,857 Added 902.73%	59,823 $3.01 Million
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $4,067 - $7,285	89 Added 1.51%	5,966 $476,000
Q3 2019 Nov 14, 2019	BUY	$45.35 - $57.91 $266,521 - $340,337	5,877 New	5,877 $285,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.